Search
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 2 of 2 items.
Sotrovimab for Injection - Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
… Last updated 2022-04-14 Summary Product Sotrovimab, 500 mg IV Issue Health products - New safety … below Audience Health professionals Affected products Sotrovimab for injection, anti-SARS-CoV-2 spike protein … 500 mg / 8 mL, single-use vial, DIN 02518341. Issue Sotrovimab, 500 mg IV, is unlikely to maintain efficacy …
AlertHealth professional risk communication | 2022-04-14
Authorization of Sotrovimab for Injection for Use in Relation to the COVID-19 Pandemic
… of medicine in hospitals. Key messages On July 30, 2021, sotrovimab for injection, a monoclonal antibody, was … and Advertising of Drugs for Use in Relation to COVID-19 . Sotrovimab is indicated for the treatment of mild to moderate … and/or death. At this time, GlaxoSmithKline is providing sotrovimab with European French and English labelling, in …
AlertHealth professional risk communication | 2021-10-04